As per the latest report by IMARC Group, titled Preimplantation Genetic Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026, the global preimplantation genetic testing market exhibited XX growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026. Preimplantation genetic testing (PGT) detects abnormal embryos and facilitates the transfer of genetically normal embryos. It also reduces the trauma of several failed in vitro fertilization (IVF) cycles and early miscarriages. Moreover, PGT is used to treat individuals with high chances of having babies with specific genetic aberrations, as it protects children from inherited monogenic disorders. Apart from this, it is utilized in hematological disorders in children and in cases of advanced maternal age to prevent the birth of a syndromic child.

Request Free Sample Report: https://www.imarcgroup.com/preimplantation-genetic-testing-market/requestsample

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Preimplantation Genetic Testing Market Trends:

Rising birth rates and incidences of spontaneous miscarriages are some of the primary factors positively influencing the demand for PGT to minimize the need for multiple IVF cycles. Additionally, the growing risks of miscarriage with the womans age, along with the emerging trend of delayed parenthood is further strengthening the global market. Besides this, the expanding medical tourism sector and improving diagnostic modalities are also bolstering the market growth. Moreover, the introduction of innovative techniques, such as microarray and genome sequencing, coupled with the escalating demand for minimally invasive (MI) procedures, is positively influencing the market. Furthermore, the rising integration of PGT technology with Assisted Reproductive Technology (ART) procedures to offer improved outcomes to patients is expected to drive the global PGT market in the coming years.

Explore Full Report with TOC & List of Figure: https://bit.ly/3zUV5Wk

Key Market Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

Breakup by Product:

Breakup by Procedure:

Breakup by Technology:

Breakup by Application:

Breakup by Region:

Key highlights of the Report:

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Contact US

IMARC Group 30 N Gould St, Ste RSheridan, WY (Wyoming) 82801 USA Email: [emailprotected]Tel No:(D) +91 120 433 0800Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

See original here:
Preimplantation Genetic Testing Market: Demand, Trends and Business Opportunities 2021-26 - The Market Writeuo - The Market Writeuo

Comments are closed.